Insulin lispro: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='96/969624/Cv/2'> | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='96/969624/Cv/2'> | ||
Insulin lispro, sold under the brand name Humalog among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_lispro]. | Insulin lispro, sold under the brand name Humalog among others, is a modified type of medical [[insulin]] used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_lispro]. Insulin lispro is a manufactured form of human insulin where the amino acids lysine and proline have been switched at the end of the B chain of the insulin molecule. This switch of amino acids mimics [[Insulin-like growth factor 1]] which also has lysine and proline in that order. | ||
<scene name='96/969624/Cv/3'>Insulin Lispro Analog</scene> ([[6nwv]]). | |||
<scene name='96/969624/Cv/4'>Insulin Lispro</scene>, Human Insulin A chains (A, C, E, G, I, K) are colored in cyan and Human Insulin B chains (B, D, F, H, J, L) are colored in magenta. | |||
<scene name='96/969624/Abdimer/1'>Insulin Lispro Analog AB heterodimer</scene>. | |||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||